Healthcare provider profile · identity verified

Emaad Basith, MD

Family Practice · DOWNERS GROVE, IL · NPI 1689025108

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	513	41
Amlodipine Besylate	Amlodipine Besylate	338	21
Mirtazapine	Mirtazapine	296	18
Levothyroxine Sodium	Levothyroxine Sodium	224	25
Escitalopram Oxalate	Escitalopram Oxalate	220	17
Eliquis	Apixaban	198	20
Lisinopril	Lisinopril	195	17
Gabapentin	Gabapentin	182	20
Levetiracetam	Levetiracetam	177	11
Metoprolol Succinate	Metoprolol Succinate	175	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	174	17
Memantine Hcl	Memantine Hcl	171	11
Pantoprazole Sodium	Pantoprazole Sodium	153	19
Bumetanide	Bumetanide	146	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	145	17
Trazodone Hcl	Trazodone Hcl	141	15
Sertraline Hcl	Sertraline Hcl	128	11
Furosemide	Furosemide	126	20
Baclofen	Baclofen	117	suppressed
Xarelto	Rivaroxaban	107	suppressed
Clopidogrel	Clopidogrel Bisulfate	104	14
Metformin Hcl	Metformin Hcl	104	14
Donepezil Hcl	Donepezil Hcl	102	12
Potassium Chloride	Potassium Chloride	99	18
Losartan Potassium	Losartan Potassium	96	11
Divalproex Sodium	Divalproex Sodium	95	12
Tamsulosin Hcl	Tamsulosin Hcl	95	19
Carbidopa-Levodopa	Carbidopa/Levodopa	92	suppressed
Carvedilol	Carvedilol	90	suppressed
Pravastatin Sodium	Pravastatin Sodium	89	suppressed
Jardiance	Empagliflozin	87	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	86	13
Risperidone	Risperidone	81	suppressed
Allopurinol	Allopurinol	78	suppressed
Bupropion Xl	Bupropion Hcl	78	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	77	suppressed
Buspirone Hcl	Buspirone Hcl	76	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	67	suppressed
Famotidine	Famotidine	67	suppressed
Olanzapine	Olanzapine	57	suppressed
Amiodarone Hcl	Amiodarone Hcl	55	suppressed
Citalopram Hbr	Citalopram Hydrobromide	55	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	55	suppressed
Spironolactone	Spironolactone	55	12
Lansoprazole	Lansoprazole	53	suppressed
Omeprazole	Omeprazole	50	12
Entresto	Sacubitril/Valsartan	49	suppressed
Fluticasone Propionate	Fluticasone Propionate	47	17
Prednisone	Prednisone	47	12
Sucralfate	Sucralfate	47	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	47	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	45	suppressed
Duloxetine Hcl	Duloxetine Hcl	44	suppressed
Benztropine Mesylate	Benztropine Mesylate	43	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	40	15
Venlafaxine Hcl Er	Venlafaxine Hcl	39	suppressed
Clonazepam	Clonazepam	38	suppressed
Nifedipine Er	Nifedipine	37	suppressed
Tramadol Hcl	Tramadol Hcl	36	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	35	suppressed
Tizanidine Hcl	Tizanidine Hcl	34	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Clonidine Hcl	Clonidine Hcl	32	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	31	22
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	30	suppressed
Alendronate Sodium	Alendronate Sodium	28	suppressed
Lorazepam	Lorazepam	28	suppressed
Humalog Kwikpen U-100	Insulin Lispro	27	suppressed
Primidone	Primidone	27	suppressed
Simvastatin	Simvastatin	27	suppressed
Mesalamine	Mesalamine	26	suppressed
Colchicine	Colchicine	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Montelukast Sodium	Montelukast Sodium	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	22	13
Oxycodone Hcl	Oxycodone Hcl	22	suppressed
Bromocriptine Mesylate	Bromocriptine Mesylate	21	suppressed
Diltiazem Hcl	Diltiazem Hcl	21	suppressed
Topiramate	Topiramate	21	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	20	suppressed
Haloperidol	Haloperidol	20	suppressed
Metronidazole	Metronidazole	20	11
Pregabalin	Pregabalin	20	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	19	11
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	18	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	17	suppressed
Glyburide	Glyburide	17	suppressed
Nystatin	Nystatin	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Admelog Solostar	Insulin Lispro	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Colestipol Hcl	Colestipol Hcl	15	suppressed
Finasteride	Finasteride	15	suppressed
Lurasidone Hcl	Lurasidone Hcl	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Nystop	Nystatin	15	suppressed
Torsemide	Torsemide	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Bethanechol Chloride	Bethanechol Chloride	13	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Cephalexin	Cephalexin	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Phenytoin	Phenytoin	13	suppressed
Diazepam	Diazepam	12	suppressed
Lacosamide	Lacosamide	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Amantadine	Amantadine Hcl	11	suppressed
Gvoke Hypopen 1-Pack	Glucagon	11	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Vancomycin Hcl	Vancomycin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error